wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q37327307-A441864F-7506-494E-A7FB-D4984871EBDB
Q37327307-A441864F-7506-494E-A7FB-D4984871EBDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37327307-A441864F-7506-494E-A7FB-D4984871EBDB
The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.
P2860
Q37327307-A441864F-7506-494E-A7FB-D4984871EBDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37327307-A441864F-7506-494E-A7FB-D4984871EBDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
283a3879050de2cee5042a71d1f76c977c2d334c
P2860
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.